Clinical Trials on Newly Diagnosed Glioblastoma in Patients ≥70 Years in New Zealand
Total 12 results
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer CenterActive, not recruiting
-
Daiichi Sankyo, Inc.PlexxikonCompletedPatients With Newly Diagnosed GlioblastomaUnited States
-
Aivita Biomedical, Inc.Active, not recruitingNewly Diagnosed GlioblastomaUnited States
-
MimiVax, LLCTranslational Drug Development; MeritActive, not recruitingNewly Diagnosed GlioblastomaUnited States
-
Northern Sydney and Central Coast Area Health ServiceMerck KGaA, Darmstadt, GermanyUnknownNewly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4Australia
-
European Organisation for Research and Treatment...Celgene; Canadian Cancer Trials GroupCompletedNewly Diagnosed GlioblastomaUnited States, Belgium, Canada, Spain, Netherlands, France, Switzerland, Germany, Norway, Denmark, Austria, United Kingdom
-
Memorial Sloan Kettering Cancer CenterJazz PharmaceuticalsWithdrawnAcute Lymphoblastic Leukemia (ALL) | Newly Diagnosed Philadelphia Chromosome Negative | Aged 60 Years or OlderUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingNewly Diagnosed or Recurrent Metastatic Melanoma Patients | Malignant Brain TumorsUnited States
-
National Institute of Diabetes and Digestive and...CompletedType 1 Diabetes | Preservation of Insulin Secretion | Newly Diagnosed Type 1 Diabetes | Canakinumab in Type 1 DiabetesUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterPharmacyclics LLC.; Janssen Biotech, Inc.RecruitingAdult Patients With Newly Diagnosed or Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL) | Or Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)United States
-
Sapience TherapeuticsRecruitingBreast Cancer | Glioblastoma | Prostate Cancer | Brain Cancer | Glioblastoma Multiforme | GBM | Metastatic Breast Cancer | Recurrent Glioblastoma | Metastatic Melanoma | Metastatic Prostate Cancer | Prostate Cancer Metastatic | Newly Diagnosed Glioblastoma | Melanoma Stage IV | Melanoma RecurrentUnited States, United Kingdom
-
NYU Langone HealthWashington University School of MedicineTerminatedPatients Who Consented to Undergo Laparoscopic Gastric Banding Surgery for Weight Loss and Consent to Participate in This studyBMI ≥35 kg/m2 | Confirmed Type 2 Diabetes Treated With Oral Agents and/or Only Diet Therapy | Age 18-64 YearsUnited States